CorMedix Inc’s recent filing unveils that its Chief Executive Officer Todisco Joseph acquired Company’s shares for reported $50718.0 on Mar 13 ’24. In the deal valued at $3.74 per share,13,561 shares were bought. As a result of this transaction, Todisco Joseph now holds 352,839 shares worth roughly $2.06 million.
Then, DUNTON ALAN W bought 3,000 shares, generating $9,900 in total proceeds. Upon buying the shares at $3.30, the Director now owns 15,250 shares.
Before that, DUNTON ALAN W bought 3,000 shares. CorMedix Inc shares valued at $10,350 were divested by the Director at a price of $3.45 per share. As a result of the transaction, DUNTON ALAN W now holds 12,250 shares, worth roughly $71540.0.
RBC Capital Mkts initiated its CorMedix Inc [CRMD] rating to an Outperform in a research note published on August 10, 2023; the price target was $6. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. JMP Securities began covering CRMD with “Mkt outperform” recommendation on September 29, 2020. Truist started covering the stock on September 21, 2020. It rated CRMD as “a Buy”.
Price Performance Review of CRMD
On Friday, CorMedix Inc [NASDAQ:CRMD] saw its stock jump 8.75% to $5.84. Over the last five days, the stock has gained 9.98%. CorMedix Inc shares have risen nearly 55.32% since the year began. Nevertheless, the stocks have risen 15.87% over the past one year. While a 52-week high of $7.00 was reached on 04/12/24, a 52-week low of $2.57 was recorded on 02/08/24. SMA at 50 days reached $4.46, while 200 days put it at $3.81. A total of 1.03 million shares were traded, compared to the trading of 0.63 million shares in the previous session.
Levels Of Support And Resistance For CRMD Stock
The 24-hour chart illustrates a support level at 5.54, which if violated will result in even more drops to 5.24. On the upside, there is a resistance level at 6.03. A further resistance level may holdings at 6.22. The Relative Strength Index (RSI) on the 14-day chart is 66.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.15%. Stochastics %K at 41.73% indicates the stock is a holding.
The most recent change occurred on December 18, 2019 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $48 price target.
